Joint radionuclide therapy-immunotherapy approach effective in prostate cancer model ...Middle East

- News
Joint radionuclide therapy-immunotherapy approach effective in prostate cancer model
A combination of radionuclide therapy and immunotherapy has proven successful in slowing the progression of prostate cancer and increasing survival time, according to new research published in the February issue of The Journal of Nuclear Medicine. The results of the murine study indicate that radionuclide therapy promotes prostate cancer immunogenicity, provoking a cellular response that makes the tumors more receptive to immunotherapy.

Hence then, the article about joint radionuclide therapy immunotherapy approach effective in prostate cancer model was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Joint radionuclide therapy-immunotherapy approach effective in prostate cancer model )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News